LEONTEQ SECURITIES AG (GUERNSEY BRANCH) | Market Closed - Swiss Exchange 11:20:00 2024-06-28 am EDT | ||
| 101 CHF | +0.18% |
|
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-06-28 | 101 | +0.18% |
| 24-06-25 | 100.8 | +0.31% |
| 24-06-24 | 100.5 | +0.10% |
Delayed Quote Swiss Exchange
Last update June 28, 2024 at 11:20 am EDT
More quotesStatic data
| Product type | Reverse Convertibles |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | LEONTEQ |
| ZMFLTQ | |
| ISIN | CH1336231936 |
| Date issued | 2024-03-28 |
| Strike | 778 $ |
| Maturity | 2025-09-29 (458 Days) |
| Parity | 1 : 1 |
| Emission price | 100 CHF |
| Emission volume | N/A |
| Settlement | both |
| Currency | CHF |
Technical Indicators
| Highest since issue | 101 CHF |
|---|---|
| Lowest since issue | 92.11 CHF |
| Spread | 8.1 CHF |
| Spread % | 0.80% |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
909
USD
Average target price
868.9
USD
Spread / Average Target
-4.41%
- Stock Market
- Certificates
- ZMFLTQ Certificat
